HUGO ARNALDO GONZALEZ VELOZO
Associate Professor
Fundación Ciencia y Vida
Santiago, Chile
Cancer Biology, Metastasis, tumor-immune crosstalk, Bioinformatics, Cancer System Biology.
-
Tecnologia Medica, UNIVERSIDAD DE TALCA. Chile, 2005
-
Tecnologo Medico, UNIVERSIDAD DE TALCA. Chile, 2005
-
Molecular Biology, UNIVERSIDAD ANDRES BELLO. Chile, 2013
-
PhD Candidate and Professor Full Time
UNIVERSIDAD ANDRES BELLO
Biological Sciences
Santiago, Chile
2008 - 2010
-
PhD Candidate Full Time
FUNDACION CIENCIA PARA LA VIDA
Santiago, Chile
2009 - 2014
-
POSTDOCTORAL FELLOW Full Time
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
SAN FRANCISCO, Estados Unidos
2015 - 2022
-
Assistant Adjunct Professor Full Time
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
San Francisco, Estados Unidos
2022 - A la fecha
-
Associate Professor Full Time
Fundacion Ciencia y Vida
Santiago, Chile
2023 - A la fecha
-
Postdoctoral Fellow Full Time
University of California San Francisco
San Francisco, Estados Unidos
2015 - 2022
-
PhD candidate and postdoctoral researcher Full Time
Fundacion Ciencia y Vida
Santiago, Chile
2009 - 2014
-
Professor Full Time
Universidad Andres Bello
Santiago, Chile
2008 - 2010
-
Assistant Adjunct Professor Full Time
University of California San Francisco
San Francisco, Estados Unidos
2022 - A la fecha
-
Associate Professor Full Time
Fundación Ciencia y Vida
Santiago, Chile
2023 - A la fecha
MENTORING AND TEACHING EXPERIENCE
Mentoring (Alumni)
• Master program mentor for Merel van Gogh, University of Utrecht, Netherlands. Current appointment: PhD candidate at University of Zurich.
• Master program Mentor for Tamara Verbeek, University of Utrecht, Netherlands. Current appointment: PhD student at University of Utrecht.
• Mentor for Wenbin Mei, Peking University, China (intern). Current appointment: PhD candidate at Rockefeller University.
• Mentor for Isabella Robles, University of California Berkeley (intern). Current appointment: Stanford University.
• Mentor for Sandhya Kalavacherla, Massachusetts Institute of Technology (MIT) (intern). Current appointment: University of California San Diego.
• Mentor for Stephen Georgiou, University of California Berkeley (intern). Current appointment: University of California San Francisco.
• Mentor for Ankitha Nanjaraj, University of California San Francisco (Research Associated). Current appointment: Sangamo Therapeutics Inc.
Collaborations with biopharmaceutical companies in the USA.
• Company: 3T BIOSCIENCES INC.
Location: South San Francisco, CA, USA.
Dates of collaboration: (12/2020-12/2021).
Role: Scientific advisor in developing new ex-vivo systems for testing next-generation T cell therapies against solid cancers.
• Company: SENTI BIOSCIENCES, INC.
Location: South San Francisco, CA, USA.
Dates of collaboration: (08/2021-Present).
Role: Scientific advisor and collaborator in developing next-generation NK cell therapies for carcinomas.
-
BECA DE POSTDOCTORADO EN EL EXTRANJERO BECAS CHILE
CONICYT
Chile, 2015
Scholarship to perform postdoctoral training in an international institution.
-
BECA DE DOCTORADO EN CHILE
CONICYT
Chile, 2010
Scholarship for Ph.D. studies in Chile.
-
BECAS DE TÉRMINO DE TESIS DOCTORAL
CONICYT
Chile, 2012
Scholarship to fund the completion of doctoral dissertation.
-
Summa Cum Laude Distinction for doctoral dissertation.
UNIVERSIDAD ANDRES BELLO
Chile, 2013
Doctoral dissertation evaluated with the highest distinction.
Dopamine receptor D5 expressed on dendritic cells promotes CD4+T-cell-mediated autoinununity |
Stimulation of dopamine receptor D3 expressed on CD4(+) T-cells favours Th1 immunity |
Role of dopamine receptors expressed on CD4+ T-cell and on dendritic cells in the development of autoimmune response and in cellular mechanisms involved in the physiopathology of multiple sclerosis |
Proyecto de inicio a la investigación para estudiantes de doctorado=> "Papel de los receptores de dopamina expresados en células T CD4+ en el desarrollo de la enfermedad de Parkinson". |
Role of dopamine receptors on the T-cell mediated immunity |
Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia |
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases |